United States · FDA National Drug Code directory
Loratadine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 21130-526_5ef0c05a-40de-40cb-b52c-3f1ab96a5348
- Product NDC
- 21130-526
- Form
- TABLET
- Composition / generic term
- Loratadine
- Labeler
- SAFEWAY INC.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090606
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (21130-526-13) / 120 TABLET in 1 BOTTLE · 21130-526-13
- 3 BLISTER PACK in 1 CARTON (21130-526-31) / 10 TABLET in 1 BLISTER PACK · 21130-526-31
- 1 BOTTLE in 1 CARTON (21130-526-38) / 365 TABLET in 1 BOTTLE · 21130-526-38
- 1 BOTTLE in 1 CARTON (21130-526-43) / 45 TABLET in 1 BOTTLE · 21130-526-43
- 1 BLISTER PACK in 1 CARTON (21130-526-69) / 10 TABLET in 1 BLISTER PACK · 21130-526-69
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →